2. Korea Centers for Disease Control and Prevention. H1N1 influenza A (H1N1) press release [Internet]. Seoul: Korea Centers for Disease Control and Prevention;2009. cited 2015 Mar 1. Available from:
http://www.cdc.go.kr/.
3. McCullers JA. Insights into the interaction between influenza virus and pneumococcus. Clin Microbiol Rev. 2006; 19:571–582.
4. Brundage JF. Interactions between influenza and bacterial respiratory pathogens: implications for pandemic preparedness. Lancet Infect Dis. 2006; 6:303–312.
5. Smith CB, Kanner RE, Golden CA, Klauber MR, Renzetti AD Jr. Effect of viral infections on pulmonary function in patients with chronic obstructive pulmonary diseases. J Infect Dis. 1980; 141:271–280.
6. Talwar A, Patel N, Omonuwa K, Lisker G. Postintubation obstructive pseudomembrane. J Bronchol. 2008; 15:110–112.
7. Nam KH, Hong JS, Hong MY, Lim JM, Kim MH, Jung BH, et al. A case of pseudomembranous tracheobronchitis complicated by coinfection of 2009 pandemic influenza A/H1N1 and Staphylococcus aureus. Infect Chemother. 2011; 43:425–428.
8. Jain S, Kamimoto L, Bramley AM, Schmitz AM, Benoit SR, Louie J, et al. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med. 2009; 361:1935–1944.
9. Chertow DS, Memoli MJ. Bacterial coinfection in influenza: a grand rounds review. JAMA. 2013; 309:275–282.
10. Tashiro M, Ciborowski P, Klenk HD, Pulverer G, Rott R. Role of Staphylococcus protease in the development of influenza pneumonia. Nature. 1987; 325:536–537.
11. Namba Y, Mihara N, Tanaka M. Fulminant tracheobronchitis caused by methicillin-resistant Staphylococcus aureus (MRSA). Nihon Kyobu Shikkan Gakkai Zasshi. 1997; 35:969–973.
12. Herrmann RE, Ogura GI, Johnson ES, Toll HW Jr, White WC. Respiratory deaths associated with Asian influenza epidemic: report of twenty-three cases. J Am Med Assoc. 1958; 166:467–471.